Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial

Pascal de Jong; Mieke Hazes; Leander Buisman; PJ Barendregt; D van Zeben; PA van der Lubbe; AH Gerards; MH de Jager; PBJ de Sonnaville; BA Grillet; J.J. Luime; Angelique Weel

Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial

Pascal de Jong, Mieke Hazes, Leander Buisman, PJ Barendregt, D van Zeben, PA van der Lubbe, AH Gerards, MH de Jager, PBJ de Sonnaville, BA Grillet, J.J. Luime, Angelique Weel

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2138-2147
Number of pages	10
Journal	Rheumatology
Volume	55
Issue number	12
Publication status	Published - 2016

Cite this

de Jong, P., Hazes, M., Buisman, L., Barendregt, PJ., van Zeben, D., van der Lubbe, PA., Gerards, AH., de Jager, MH., de Sonnaville, PBJ., Grillet, BA., Luime, J. J., & Weel, A. (2016). Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial. Rheumatology, 55(12), 2138-2147.

@article{bb75c959d3344dc6bb1e45c47ff42a08,

title = "Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial",

author = "{de Jong}, Pascal and Mieke Hazes and Leander Buisman and PJ Barendregt and {van Zeben}, D and {van der Lubbe}, PA and AH Gerards and {de Jager}, MH and {de Sonnaville}, PBJ and BA Grillet and J.J. Luime and Angelique Weel",

year = "2016",

language = "Undefined/Unknown",

volume = "55",

pages = "2138--2147",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "12",

}

de Jong, P , Hazes, M, Buisman, L, Barendregt, PJ, van Zeben, D, van der Lubbe, PA, Gerards, AH, de Jager, MH, de Sonnaville, PBJ, Grillet, BA, Luime, JJ & Weel, A 2016, 'Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial', Rheumatology, vol. 55, no. 12, pp. 2138-2147.

Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial. / de Jong, Pascal ; Hazes, Mieke; Buisman, Leander et al.

In: Rheumatology, Vol. 55, No. 12, 2016, p. 2138-2147.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial

AU - de Jong, Pascal

AU - Hazes, Mieke

AU - Buisman, Leander

AU - Barendregt, PJ

AU - van Zeben, D

AU - van der Lubbe, PA

AU - Gerards, AH

AU - de Jager, MH

AU - de Sonnaville, PBJ

AU - Grillet, BA

AU - Luime, J.J.

AU - Weel, Angelique

PY - 2016

Y1 - 2016

M3 - Article

VL - 55

SP - 2138

EP - 2147

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 12

ER -